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A C-terminal segment of mitochondrial human liver aldehyde dehydrogenase was characterized. The 
results prove that a central part of this segment largely but not completely agrees with a structure of a 
tryptic peptide previously reported for the same isoenzyme. This part corresponds to a segment that 
contains the exchanged residue in the functionally deficient Oriental variant of mitochondrial aldehyde 
dehydrogenase [(1984) Proc. Natl. Acad. Sci. USA 81, 258-2611. The data suggest important functions 
for the C-terminal region of aldehyde dehydrogenase, clarify previously inconsistent results, and establish 
this structure in the typical enzyme, including the position corresponding to the mutation in the functional 
variant. 
Mtochondrial isoenzyme Amino acid sequence Isoenzyme difference 
Structure-function relationship 
1. INTRODUCTION 
The low tolerance to ethanol often observed 
among Oriental individuals [l-3] can be correlated 
with elevated levels of acetaldehyde after ethanol 
consumption [2-31. Such increased levels may be 
facilitated by two enzyme variants frequently oc- 
curring in Oriental livers and caused by allelic 
variations. Thus, the presence of a more active 
variant of alcohol dehydrogenase [4,5], an inactive 
variant of the mitochondrial isoenzyme of 
aldehyde dehydrogenase [6], or both may explain 
the intolerance. The molecular alteration in the 
variant alcohol dehydrogenase (‘atypical’ alcohol 
dehydrogenase) is due to an allele at the ADW2 
locus [7] coding for ,& chains. Such alcohol 
dehydrogenase subunits from Oriental and Cauca- 
sian populations (&-Oriental and &-Bern chains, 
respectively) have been characterized and shown to 
be identical [5,8], reflecting only relative dif- 
ferences in the gene occurrence between the two 
populations. The other molecular alteration, in the 
mitochondrial human liver aldehyde dehydro- 
genase, has also been studied and a mutation sug- 
gested [6]. 
* To whom correspondence should be addressed 
The established difference in the Oriental 
alcohol dehydrogenase can be functionally inter- 
preted since the structure of the corresponding 
protein is well known [9]. The increased enzyme 
activity and aldehyde concentration are explained 
by a His/Arg substitution, affecting coenzyme- 
binding and therefore the rate-limiting step in 
aldehyde formation [5,8]. The difference suggested 
for aldehyde dehydrogenase [6] has not been cor- 
respondingly interpreted in functional terms 
because of lack of knowledge of the whole enzyme 
structure. Now, however, characterization and 
further interpretation of the difference in human 
mitochondrial aldehyde dehydrogenase are possi- 
ble. Thus, the first primary structure of a liver 
Published by Elsevier Science Publishers B. V. 
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aldehyde dehydrogenase (the human cytoplasmic 
isoenzyme) has recently been determined [lo], 
chemical modifications have correlated two 
segments with enzyme activity [l l-131, segments 
possibly forming the ,&fl coenzyme-binding fold 
have been identified [lo], and comparatively dis- 
tant relationships between the mitochondrial and 
cytoplasmic isoenzymes have been established [ 141. 
Using this background information to position 
the 1Cresidue segment suggested an explanation 
for the difference in the Oriental variant of inac- 
tive mitochondrial aldehyde dehydrogenase [6]: it 
is found that the altered segment appears to corres- 
pond to the region Glu-476--Lys-489 near the C- 
terminus of the 500-residue subunit of the 
cytoplasmic isoenzyme. However, the structure 
reported for the segment suggested to be altered in 
the mitochondrial enzyme is somewhat different 
and does not exactly fit the primary structure of 
the cytoplasmic [IO] or mitochondrial (unpub- 
lished) enzymes. Consequently, the suggested 
alteration [6] is unclear and assignments not 
established. Therefore, the 30-residue C-terminal 
CNBr fragment of human mitochondrial liver 
aldehyde dehydrogenase was here isolated and ful- 
ly characterized. The results clarify previous incon- 
sistencies and also define the structure in the 
typical enzyme that locates the previously reported 
substitution in the variant enzyme [6] at position 
- 14 from the C-terminus. 
2. MATERIALS AND METHODS 
Human liver mitochondrial aldehyde dehydro- 
genase was prepared as described [ 151. Carboxy- 
methylation, CNBr cleavage, prefractionation on 
Sephadex G-50 fine, high-performance liquid 
chromatography (HPLC) onpBondapak (Waters), 
redigestion with the Glu-specific Staphylococcal 
protease (Miles), acid hydrolysis, liquid phase se- 
quencer analysis and manual sequence degradation 
by the dimethylaminoazobenzene (DABITC) 
double-coupling method [16,17] were carried out 
exactly as described for the cytoplasmic isoenzyme 
[lOI* 
3. RESULTS 
The CNBr fragments from carboxymethylated 
human liver mitochondrial aldehyde dehydro- 
genase were applied to Sephadex G-50 fine. Frac- 
tions at an elution volume corresponding to 
fragments of about 30 residues contained the 
original C-terminus (unpublished) and were pooled 
and re-purified by reverse-phase high performance 
liquid chromatography (RP-HPLC) (fig. 1A). The 
largest peak, eluting at 3 1 Vo acetonitrile, contained 
material which was sufficiently pure to provide the 
amino acid sequence of the first 29 residues in the 
fragment by direct, manual DABITC degradation 
(fig.2). However, small amounts of a contaminant 
beginning with alanine were also present and 
especially disturbed the analysis for total composi- 
tion (yielding too high Asp and Ala). Repurifica- 
tion by RP-HPLC using a Novapak (Waters) col- 
umn was therefore necessary and yielded a pure 
product with a composition in full agreement with 
the amino acid sequence determined. The composi- 
tion is given in table 1. 
For confirmation of the structure and final 
establishment of all residues, the pure fragment 
was redigested with the Glu-specific staphylococcal 
protease. The resultant peptides were also 
separated by RP-HPLC (fig. 1B) and fully degrad- 
ed for sequence analysis. Total compositions are 
listed in table 1, and the structures are given in 
fig.2. Peptides Sl and S2 were analyzed by the 
manual DABITC method, S3 and S4 by liquid 
phase sequencer analysis, in which case further 
details are given in table 2. Combined, all results 
define the 30-residue C-terminal CNBr fragment 
of mitochondrial human liver aldehyde dehydro- 
genase to have the structure shown in fig.2. 
- 
Fig.1. RP-HPLC separation of peptides analyzed. (A) Separation of the C-terminal CNBr fragment (c) after pre- 
fractionation on Sephadex G-50 fine of a whole CNBr digest of human liver mitochondrial aldehyde dehydrogenase. 
Material applied: pooled eluate between 220-250 ml from a 1.5 x 190 cm Sephadex column. HPLC conditions: 
gradient (olo B) of acetonitrile as shown, against 0.1% trifluoroacetic acid. Column packing: ,uBondapak RP-18 
(Waters). (B) Separation of peptides obtained after redigestion with staphylococcal Glu-specific protease of the 
fragment indicated by (-+) in A. Chromatographic conditions as in A, peptide designations as in fig.2. 
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SGSG~ELGEYGLQAYTEVK?“TVK~PQKN~ Fig.2. The amino acid sequence of the C-terminal CNBr 
I -I fragment isolated as in fig.1, together with positions of 
Intact CNBr fragment all peptides used to determine the structure. Peptides 
I 
W-W Sl-S4 denote products obtained after redigestion with 
52 53 54 Glu-specific staphylococcal protease (an uncleaved 
,&------_-4 
52 - 53 
product, S2-S3, was also recovered, as indicated). Solid . 
lines show residues identified in a peptide by manual 
DABITC degradations (intact CNBr fragment, Sl, S2) 
or liquid phase sequencer degradations (S3 and S4, 
details in table 2). 
(471) (480) (490) (500) 
Ser-Gly-Asn-Gly-Arg-Glu-Leu-Gly-Glu-Tyr-Gly-Phe-His-Glu-Tyr-Thr-Glu-Val-Lys-Thr-Val-Thr-Val-Lys-lle-Ser-Gln-Lys-Asn-Ser 
~~;;-Gly-Ser-Gly-Arg-G1u-Leu-Gly-Glu-Tyr-Gly-Leu-G1n-Ala-Tyr-Thr-~-Val-Lys-Thr-Val-Thr-Val-Lys-Val-Pro-G1n-Lys-Asn-Ser 
-20 -10 -1 
Glu-Leu-Gly-Glu~l~Gly-Leu-G1n-Ala~sn~al)-(Gln~Val-Lys 
Fig.3. Comparison between the structures of the normal mitochondrial human liver aldehyde dehydrogenase (middle 
line; this work), the normal cytoplasmic isoenzyme (top line; [lo]) and the previously suggested structure of a tryptic 
peptide from the mitochondrial isoenzyme (bottom line; [6]). Positional numbers below the middle line refer to positions 
from the protein C-termini at - 1. Positional numbers above the sequence refer to the actual numbers in the whole 
structure of the cytoplasmic isoenzyme chain [lo]. The 6 residues which differ between the isoenzymes are bold-faced 
in the top line. In the case of the previously reported tryptic peptide, the 4 residues which deviate from the present 
structure are given within parentheses, being derived from the same protein as presently analyzed but reported 
differently. The underlined residue at position - 14 corresponds to the residue that has been reported to differ in the 
mutant variant of Oriental human liver mitochondrial aldehyde dehydrogenase [6]. 
Table 1 
Amino acid compositions of peptides used in the determination of the structure of the C-terminal 
CNBr fragment from human liver mitochondrial aldehyde dehydrogenase 
Peptide Intact 
CNBr 
fragment 
Sl s2 s3 s4 
CYS 
Asx 
Thr 
Ser 
Glx 
Pro 
Gly 
Ala 
Val 
Met 
Be 
Leu 
Tyr 
Phe 
Trp 
LYS 
His 
Arg 
- - 
1.1 (1) 
2.8 (3) 
2.8 (3) 
4.9 (5) 
1.1 (1) 
4.0 (4) 
1.1 (1) 
3.9 (4) 
- - 
- - 
2.0 (2) 
2.0 (2) 
- - 
- - 
2.8 (3) 
- - 
0.9 (1) 
Sum 30 
N-terminus Ser 
- - 
1.0 (1) 
1.8 (2) 
0.9 (1) 
1.0 (1) 
1.0 (1) 
- - - - - - 
0.9 (1) 
- - 
2.0 (2) 
- - 
1.1 (1) 
1.0 (1) 
- - 
- - 
2.0 (2) 
1.1 (1) 
- - 
2.2 (2) 
- - 
- - 
- - 
1.0 (1) 
- - 
1.0 (1) 
- - 
- - 
3.9 (4) 
- - 
- - - - 
- - - - - - 
- - - _ 
1.0 (1) 
- - 
- - 
1.0 (1) 
2.0 (2) 
- - 
- - 
- - - - 
- - - - 
- - - - 
- - - - - - - - 
3.1 (3) 
- - 
- - - _ - - 
- - 
1.0 (1) 
6 
Ser 
- - - - 
- - - - 
3 
J-W 
8 
TYr 
13 
Val 
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Table 2 
Results of liquid phase sequencer degradations of peptides S3 and S4. 
Phenylthiohydantoin identifications were by high-performance liquid chromatography 
(H) and thin-layer chromatography (T) 
Cycle s3 s4 
Residue Method nmol Residue Method nmol 
1 Tyr HT 6 1 Val HT 13 
2 Gly HT 3 2 LYS HT 11 
3 Leu HT 7 3 Thr HT 6 
4 Gln HT 5 4 Val HT 8 
5 Ala HT 4 5 Thr HT 3 
6 Tyr HT 5 6 Val HT 11 
7 Thr HT 4 7 Lys HT 10 
8 Glu HT 2 8 Val HT 12 
9 Pro H 2 
10 Gln HT 4 
11 Lys HT 5 
12 Asn HT 4 
13 Ser H 1 
4. DISCUSSION 
4.1. Location of a previously reported difference 
in an aldehyde dehydrogenase variant 
A segment of human liver mitochondrial 
aldehyde dehydrogenase, reported to differ in the 
Oriental variant of this isoenzyme, has been 
described [6], but it could not be positioned in the 
whole protein chain, which was then un- 
characterized. Knowledge of the entire primary 
structure [lo] of the highly different but still clear- 
ly homologous [ 141 cytoplasmic isoenzyme reveal- 
ed that the segment was similar in structure to the 
region composed of Glu-476 to Lys-489 in the C- 
terminal part of the cytoplasmic enzyme. These 
results suggest that the mutational difference in 
Oriental aldehyde dehydrogenase should be close 
to the C-terminus, although data were indirect 
(based on homology) and not completely consis- 
tent since the preliminary structure for the 
mitochondrial enzyme (unpublished) was not iden- 
tical to that reported for the segment with a muta- 
tional difference. 
Here, the C-terminal CNBr fragment of the 
mitochondrial enzyme was fully characterized 
(fig.2). The fragment is known to be derived from 
the C-terminal region by two independent sets of 
data. First, it is a CNBr fragment without C- 
terminal Hsl/Hse, suggesting origin from a protein 
C-terminus. Secondly, the fragment is closely 
homologous with the established C-terminal part 
of the cytoplasmic isoenzyme. As shown in fig.3, 
all but 6 of the 30 positions in the fragment 
described here (fig.2) are identical to the C- 
terminal counterpart from the cytoplasmic isoen- 
zyme [IO] and all residue exchanges are compatible 
with single-base mutations. This region is therefore 
a more conserved region between the two isoen- 
zymes than another region compared earlier [14], 
where 11 of 22 positions showed exchanges, many 
requiring 2-base changes. Thus, the segment 
reported to differ [6] between Oriental and typical 
mitochondrial aldehyde dehydrogenases i close to 
the C-terminus, as summarized in fig.3. The actual 
mutation reported [6] corresponds to position - 14 
from the C-terminus (fig.3). 
Functionally, an alteration at position - 14 
resulting in diminished catalytic activity as observ- 
ed in the Oriental enzyme [a], is compatible with 
the proximity in primary structure between this 
region and the segment just upstream from it that 
contains cysteine residues (at positions 455 and 463 
in the human cytoplasmic isoenzyme [lo]) sug- 
gested to be near the active site from labelling of 
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the horse liver mitochondrial isoenzyme with a 
coenzyme analog [ll]. Although the Oriental 
variant enzyme has been reported to have 
coenzyme-binding parameters nearly identical to 
those of the Caucasian typical enzyme [18], the 
Oriental variant enzyme has also been reported no 
longer to bind NAD or NADH [4]. Since the 
upstream cysteine-containing region is also im- 
plicated in coenzyme binding, the combined find- 
ings suggest important functions for the C- 
terminal region of aldehyde dehydrogenase. 
4.2. Structure of the C-terminal region and nature 
of the mutational difference 
The results show that the C-terminal region of 
mitochondrial aldehyde dehydrogenase has the 
structure shown in fig.3. As mentioned above, this 
structure contains the tryptic peptide (correspond- 
ing to positions - 25 to - 12 in fig.3) previously 
suggested to constitute the segment differing in the 
Oriental enzyme. This tryptic peptide fits nowhere 
else in the entire protein chain of mitochondrial 
aldehyde dehydrogenase (unpublished). However, 
the structure in the previous report [6] is not iden- 
tical to the present one but has deviations at 4 posi- 
tions (fig.3). It is likely that the deviations are due 
to previous misinterpretations. The reason is 
unknown, but it should be noticed that the isoen- 
zyme studied previously and now is the same and 
that present analyses have full support by complete 
agreement, not only between compositions and se- 
quences, but also between the analyses of the intact 
peptide and the redigested fragments. Consequent- 
ly, the structure is deduced to be as presently 
reported. This also applies to the chemically 
smallest deviation, which actually concerns the 
residue in the position corresponding to the muta- 
tion in the variant Oriental enzyme. This was 
previously reported as Gln but is now shown to be 
Glu at position - 14 (fig.3). The Glu is proven 
both by direct identification in manual (fig.2) and 
liquid phase sequencer (table 2) degradations, and 
by the specificity of the staphylococcal protease 
which cleaved after this residue. As a further check 
against the possibility that a deamidation had oc- 
curred, the incomplete cleavage product eluting at 
38 ml in fig.lB was analyzed and found to be 
Leu-7 - Glu-17 (cf. fig.2). 
The mutation in liver mitochondrial aldehyde 
dehydrogenase which is prevalent among Orientals 
372 
thus appears not to originate from a structure with 
Gln as previously reported [6] but from one with 
Glu (cf. position - 14, fig.3). Biochemically, this 
mutation is still a plausible alternative, since 
Glu - Lys is compatible with a single base muta- 
tion. As noted above, its position is also compati- 
ble with the functional consequences observed. 
In summary, the residue at the position cor- 
responding to the reported mutational difference 
in variant Oriental aldehyde dehydrogenase has 
been clarified in the typical, fully active mitochon- 
drial isoenzyme. This residue is glutamic acid, oc- 
cupying position - 14 from the C-terminus, and 
the surrounding structure has been fully 
characterized. 
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